
Manufacturing · NSE / BSE
Indogulf Cropsciences Limited, established in 1993, is an Indian company involved in the production of crop protection products, plant nutrients, and biologicals. In 2019, it began manufacturing Spiromesifen technical with 96.5% purity and became one of the first local producers of Pyrazosulfuron Ethyl technical with 97% purity. The company operates four manufacturing units spread across approximately twenty acres in Samba (Jammu & Kashmir) and Nathupur and Barwasni in Haryana. It has a strong sales presence in 22 Indian states and 3 Union Territories, supported by 169 business partners, 5,772 distributors, and 129 international partners across 34 countries. Its flexible and multi-purpose production facilities allow it to adapt quickly to different customer needs. The company benefits from high entry barriers in the agrochemical sector, such as high costs and complex regulatory approvals. Indogulf's product range includes plant nutrients like specialty fertilizers and soil health products that improve fertility, root growth, and crop yield. Its crop protection offerings consist of insecticides, fungicides, herbicides, and bio-stimulants that help protect crops from pests, diseases, and weeds. The company also provides biologicals such as bio-fertilizers and bio-stimulants to enhance nutrient uptake, stress tolerance, and sustainable farming. Popular products in this category include Biogold, Indo Breeza, and Indo Mychoriza. As of August 31, 2024, the company employed 640 permanent staff members.
Price Band
₹105 – ₹111
Issue Size
₹200 Cr
Lot Size
135 shares
GMP
+16.2%
Est. Listing
₹129
at current GMP
Subscribed
25.99x
overall
Open
26 Jun 2025
Close
30 Jun 2025
Allotment
1 Jul 2025
Refund
2 Jul 2025
Demat Credit
3 Jul 2025
Listing
3 Jul 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹111
Band: ₹105 – ₹111
Estimated Listing Price
₹129
Upper price + GMP
Lot Size
135 shares
Min investment ₹14,985
Estimated Profit / Lot
₹2,430
135 × ₹18
Grey Market Premium trend
+₹18
▲ 0 today
Updated 1 minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹18 | 16.2% | ₹129 |
| 30 Oct 2026 | +₹18 | 16.2% | ₹129 |
| 29 Oct 2026 | +₹16 | 14.6% | ₹127 |
GMP is unofficial market data. Not a guarantee of listing performance.
Indogulf Cropsciences Limited is bringing an initial public offering (IPO) in the Manufacturing sector with an aggregate issue size of ₹200 Crores. The shares are offered at a price band of ₹105 to ₹111 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-06-30, the basis of allotment is scheduled to be finalized on 2025-07-01. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
The latest grey market premium for Indogulf Cropsciences Limited IPO is ₹18, which indicates an expected listing price of ₹129.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.